Max Healthcare Institute Statistics
Total Valuation
NSE:MAXHEALTH has a market cap or net worth of INR 1.07 trillion. The enterprise value is 1.07 trillion.
Market Cap | 1.07T |
Enterprise Value | 1.07T |
Important Dates
The next estimated earnings date is Wednesday, May 28, 2025.
Earnings Date | May 28, 2025 |
Ex-Dividend Date | Aug 23, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.35% |
Shares Change (QoQ) | +0.02% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 669.87M |
Valuation Ratios
The trailing PE ratio is 105.72.
PE Ratio | 105.72 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 32.56 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 106.20 |
EV / Sales | 16.37 |
EV / EBITDA | 64.45 |
EV / EBIT | 75.53 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.20 |
Debt / EBITDA | 1.06 |
Debt / FCF | n/a |
Interest Coverage | 12.31 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 9.29% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 3.35M |
Profits Per Employee | 517,138 |
Employee Count | 19,500 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +36.73% in the last 52 weeks. The beta is 0.28, so NSE:MAXHEALTH's price volatility has been lower than the market average.
Beta (5Y) | 0.28 |
52-Week Price Change | +36.73% |
50-Day Moving Average | 1,052.26 |
200-Day Moving Average | 998.57 |
Relative Strength Index (RSI) | 54.38 |
Average Volume (20 Days) | 2,634,292 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:MAXHEALTH had revenue of INR 65.42 billion and earned 10.08 billion in profits. Earnings per share was 10.31.
Revenue | 65.42B |
Gross Profit | 40.78B |
Operating Income | 14.18B |
Pretax Income | 13.40B |
Net Income | 10.08B |
EBITDA | 16.31B |
EBIT | 14.18B |
Earnings Per Share (EPS) | 10.31 |
Balance Sheet
The company has 12.86 billion in cash and 17.68 billion in debt, giving a net cash position of -4.82 billion.
Cash & Cash Equivalents | 12.86B |
Total Debt | 17.68B |
Net Cash | -4.82B |
Net Cash Per Share | n/a |
Equity (Book Value) | 87.99B |
Book Value Per Share | 90.55 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 62.34%, with operating and profit margins of 21.67% and 15.42%.
Gross Margin | 62.34% |
Operating Margin | 21.67% |
Pretax Margin | 20.48% |
Profit Margin | 15.42% |
EBITDA Margin | 24.93% |
EBIT Margin | 21.67% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 0.14%.
Dividend Per Share | 1.50 |
Dividend Yield | 0.14% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 2 |
Payout Ratio | n/a |
Buyback Yield | -0.35% |
Shareholder Yield | -0.21% |
Earnings Yield | 0.95% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |